Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System

NEXT STORY
Immunotherapy Drugs Market Size to Reach USD 365.57 Billion by 2027 | Rising Advent of Biologics and Increasing Demand for Monoclonal Antibodies are Significant Factors Influencing Industry Growth, says Emergen Research
PREV STORY
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Foamix Reports Third Quarter 2015 Financial Results and Provides Business Update

REHOVOT, Israel, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) ("Foamix Pharmaceuticals"), ...

author_avatar
NASDAQ Market News

GENFIT Signs an Agreement for the Enhancement of Medical Knowledge & Landscape of NASH Research

GENFIT Signs an Agreement for the Enhancement of Medical Knowledge & Landscape of NASH ...

author_avatar
NASDAQ Market News

Exergen TemporalScanner Thermometer Featured on NBC’s Hit Medical Drama, Chicago Med

WATERTOWN, Mass., March 23, 2016 (GLOBE NEWSWIRE) -- The Exergen TemporalScanner that is used ...

author_avatar
NASDAQ Market News